|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's Range||101.12 - 102.35|
|52 Week Range||78.97 - 104.82|
|PE Ratio (TTM)||28.97|
|Earnings Date||Jul 18, 2018 - Jul 23, 2018|
|Forward Dividend & Yield||0.64 (0.66%)|
|1y Target Est||111.44|
United Technologies' (UTX) Climate, Controls & Security segment enters into a definitive agreement with The Middleby Corporation (MIDD) to sell Taylor Company.
Roche’s (RHHBY) Diagnostics division comprises tissue diagnostics, molecular diagnostics, diabetes care, and centralized and point-of-care solutions. Roche’s Diagnostics division grew 5.0% year-over-year to reach ~2.9 billion Swiss francs.
General Electric's (GE) Power Services business discloses advanced capabilities which will boost the performance and reliability of other OEM gas turbine fleets.
The Zacks Analyst Blog Highlights: Mastercard, NVIDIA, Danaher, Automatic Data Processing and Altria
Stock Research Monitor: CMI, DCI, and DOV LONDON, UK / ACCESSWIRE / May 14, 2018 / If you want a free Stock Review on DHR sign up now at www.wallstequities.com/registration . On Friday, May 11, 2018, US ...
WASHINGTON , May 8, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.16 per share payable on July 27, 2018 ...
NEW YORK, May 08, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Cboe ...
WASHINGTON , May 7, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas , will be presenting at the Bank of America ...
Dentsply Sirona (XRAY) is one of the leading dental technology providers in the United States. The company will announce its 1Q18 earnings results on May 7. It’s currently undergoing a restructuring program after failing to realize the expected synergies from its Dentsply International and Sirona Dental Systems merger in February 2016.
The stock's moving averages (the blue and gold lines in the top panel above) have positive slopes, while the On-Balance-Volume (OBV) line has been steady. The weekly OBV line is also solid on this time frame, while the MACD oscillator is poised for an upside/bullish crossover. A nearby price target of $106 is shown, but that will be good enough for a breakout in my opinion.
On CNBC's "Mad Money Lightning Round" , Jim Cramer said Snap Inc (NYSE: SNAP ) is going lower. Cramer likes GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH ). Limelight Networks, Inc. (NASDAQ: LLNW ...
LONDON, UK / ACCESSWIRE / May 03, 2018 / Active-Investors.com has just released a free earnings report on Danaher Corp. (NYSE: DHR). The Company reported its first quarter fiscal 2018 operating and financial results on April 19, 2018. Additionally, the Company raised its adjusted earnings guidance for FY18.
You might have wondered which CEOs bring home the most pay relative to their employees. This year, you get to find out, courtesy of the Dodd-Frank Act.
First-of-its-kind hematology-based test intended to alert emergency department clinicians to the possibility of sepsis or risk of developing sepsis as part of a routine CBC with differential test BREA, ...
BREA, Calif., May 1, 2018 /PRNewswire/ -- Beckman Coulter announced today the release of the DxH 900 hematology analyzer, giving mid- to high-volume clinical laboratories the ability to perform complete blood count and white blood cell differential tests with minimal repeats. The DxH 900 is now available for sale in Europe, the United States, Canada, Australia and New Zealand. The DxH 900 analyzer offers advanced technologies to support patient care, by delivering the right results the first time.
Danaher Corp. recently expressed interest in a deal for General Electric Co.’s life-sciences business, but GE didn’t engage and isn’t pursuing a deal, according to people familiar with the matter. The unit could be worth more than $20 billion, according to analyst estimates and based on how much life-sciences businesses have fetched in recent deals. The abortive approach is one of a number GE has received for various businesses recently as competitors seek to gain advantage from its weakness, and shows how the once-mighty company’s fortunes have fallen.
Crane's (CR) decent first-quarter 2018 earnings can be attributed to strong performances at its Aerospace & Electronics, and Payment & Merchandising Technologies segments.
Increase in demand by the commercial aviation industry and spending by the defense industry drove United Technologies' (UTX) Q1 earnings.
This stock has a demonstrable record of keeping up revenue in a downturn and long-term secular growth prospects.